A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)
Status:
Completed
Trial end date:
2017-11-23
Target enrollment:
Participant gender:
Summary
This is a single center, inpatient, open label pharmacodynamic study to determine the effect
of 5 g and 10 g doses of Sodium Zirconium Cyclosilicate (ZS) administered once daily (qd) for
4 days on potassium and sodium excretion in healthy Chinese subjects on a standardized, low
sodium and high potassium diet.